Skip to content
Save 5% on your next order with code PREMIUM5!
100,000+ Products for Home, Medical, Office & Classroom Needs
Search
Skip to product information
1 of 1

Mergers and Acquisitions in the Global Pharmaceutical Industry - Paperback

$34.43 USD
$34.43 USD
Sale Sold out
Shipping calculated at checkout.
In stock (100 units), ready to be shipped

Available Offers

Fast delivery available on most orders

Multiple secure payment options accepted

Secure checkout with
  • American Express
  • Apple Pay
  • Bancontact
  • Diners Club
  • Discover
  • Google Pay
  • Mastercard
  • PayPal
  • Shop Pay
  • Visa
View Product Details

Product Description

by Mennen (Author), Abayomi (Author), Jian (Author)

Project Report from the year 2006 in the subject Communications - Public Relations, Advertising, Marketing, Social Media, grade: 65 % - B, University of Sunderland, course: Global Corporate Strategy, language: English, abstract: Mergers and acquisitions are of major importance in the pharmaceutical industry. In order to evaluate the dynamics of this particular industry, this paper critically evaluates the pre- and post- merger situation of GlaxoSmithKline concerning its ready-access to markets, know-how and management capability. Furthermore, strengths and weaknesses and merger's outcomes will be outlined. Critical push and pull factors affecting M&A activity in North America will be analysed, using Pfizer and Pharmacia as an example. In addition, general reasons for M&A failure in the pharmaceutical industry will be illustrated focussing on the M&A activity of GlaxoSmithKline. Finally, using two global pharmaceutical players (GSK and Astrazeneca), the merits and demerits of the McKinsey's five step programme will be discussed.

Number of Pages: 64
Dimensions: 0.15 x 8.27 x 5.83 IN
Publication Date: August 09, 2013